Tuesday, January 31, 2023

January 31, 2023 at 08:17PM Industry (Biologics)

CBER’s Manufacturers Assistance and Technical Training Branch provides assistance and training to industry, including large and small manufacturers and trade associations, and to respond to requests for information regarding CBER policies and procedures.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Elx2Fw9

January 30, 2023 at 10:11PM Guidance Agenda: Guidance Documents CBER is Planning to Publish During Calendar Year 2023

This is the list of guidance topics CBER is considering for development during Calendar Year 2023

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/rcv5lyH

January 30, 2023 at 07:43PM Biological Approvals by Year

A collection of biological approval information organized by year and regulatory authorities.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/7Jca4RD

Friday, January 27, 2023

January 27, 2023 at 06:42PM Anti-Human Globulin Anti-C3d FFMU, Murine Monoclonal

For further manufacturing use in the production of Anti-C3d AHG Blood Grouping Reagent under a Shared Manufacturing Agreement with Diagnostic Grifols, S.A.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/WLl2ra6

January 23, 2023 at 01:28PM ODACTRA

Product approval information for use in adults 18 through 65 years of age as immunotherapy for house dust mite- (HDM)-induced allergic rhinitis, with or without conjunctivitis, confirmed by in vitro testing for IgE antibodies to Dermatophagoides farinae or Dermatophagoides pteronyssinus house dust mites, or skin testing to licensed house dust mite allergen extracts.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/yoxSsZi

January 27, 2023 at 04:14PM Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products - Questions and Answers

Questions and answers for potential blood donors and blood recipients are provided. FDA revised its blood donor deferral recommendations for men who have had sex with other men (MSM) as well as those who have hemophilia or related clotting disorders.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/m7wyL56

January 27, 2023 at 03:39PM Have You Given Blood Lately?

FDA works to ensure the safety of the more than 14 million units of blood and blood components donated in the U.S. each year. Learn how FDA helps safeguard the blood supply and how you can donate blood.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/plH0I21

January 27, 2023 at 02:49PM Blood Guidances

This page contains a listing of Blood Guidances guidances.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/KdMYOWp

January 27, 2023 at 02:49PM Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products

This is the Draft Guidance for Industry Recommendations for Evaluating Donor Eligibility Using Individual Risk-Based Questions to Reduce the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/mSZ3DxY

Wednesday, January 25, 2023

January 25, 2023 at 09:49PM Multilingual COVID-19 Resources

The U.S. Centers for Disease Control and Prevention (CDC), and international and U.S. Government partners including FDA, are addressing an outbreak of coronavirus disease 2019 (COVID-19).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/6DfoL3q

January 25, 2023 at 09:43PM DENGVAXIA

DENGVAXIA For the prevention of dengue disease caused by dengue virus serotypes 1, 2, 3 and 4. DENGVAXIA is approved for use in individuals 9 through 16 years of age with laboratoryconfirmed previous dengue infection and living in endemic areas.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/6yfbP7g

January 25, 2023 at 06:40PM Temporada de huracanes: Prepárese

Es importante preparar las provisiones de emergencia y mantener a salvo los alimentos, el agua y los medicamentos antes, durante y después de cualquier cambio climático severo.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/54cQ3lC

January 25, 2023 at 12:45PM Coral Snake Antivenom

Coral Snake Antivenom product was manufactured by Wyeth Pharmaceuticals, now a wholly owned subsidiary of Pfizer, Inc. FDA has extended the expiration date on this lot of Antivenin (Micrurus fulvius) (Equine Origin), from January 31, 2018, to January 31, 2019. The extension is based upon FDA evaluation of stability data, which determined that this lot of product will maintain stability and potency for an additional year.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ZTj0vVC

Tuesday, January 24, 2023

January 24, 2023 at 03:07PM Recalls (Biologics)

Biologic recalls are listed by year. Recalls are a firm's removal or correction of a marketed product that the FDA considers to be in violation of the laws it administers and against which the agency would initiate legal action.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/rn3lQpu

Monday, January 23, 2023

January 23, 2023 at 06:58PM Study Data Technical Conformance Guide - Technical Specifications Document

This technical specifications document represents the Food and Drug Administration's (FDA's) current thinking on this topic.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/nJ8w7Ki

January 23, 2023 at 01:29PM Vaccines and Related Biological Products Advisory Committee January 26, 2023 Meeting Announcement - 01/26/2023

This is the main page for the CBER Vaccines and Related Biological Products Advisory Committee (VRBPAC) January 26, 2023 Meeting Announcement and meeting materials.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/KJDeLAH

Friday, January 20, 2023

January 20, 2023 at 10:04PM COVID-19 Vaccines

FDA has rigorous scientific and regulatory processes in place to facilitate development and ensure the safety, effectiveness and quality of COVID-19 vaccines.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ipbuTAn

January 20, 2023 at 08:05PM Training Course: Achieving Data Quality and Integrity in Maximum Containment Laboratories

To help address challenges associated with ensuring data quality and integrity in regulated studies conducted in BSL-4 laboratories to support MCM development, FDA and UTMB collaborate to provide an annual training course on how to meet GLP requirements in BSL-4 facilities

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Lycm0TG

January 20, 2023 at 05:44PM Biologics PREA Reviews and Labeling Changes

PREA Labeling Changes, Medical, Statistical, and Clinical Pharmacology Reviews of Pediatric Studies Conducted under Section 505B of the Federal Food, Drug, and Cosmetic Act (the Act), as amended by the FDA Amendments Act of 2007 (FDAAA). These assessments are for CBER regulated drugs approved under section 505 of the Act and biological drugs licensed under section 351 of the Public Health Service Act.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ak843bd

Thursday, January 19, 2023

January 19, 2023 at 10:00PM Administrative Guidances

This page lists Administrative Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/xrSN1oG

January 19, 2023 at 08:56PM Remarks by Commissioner Robert M. Califf, M.D. at the FDA-U.S. Patent and Trademark Office Public Workshop - 01/19/2023

Remarks by Commissioner Robert M. Califf,
FDA-U.S. Patent and Trademark Office Public Workshop
Jan. 19, 2023
Washington, DC

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/uph4ef5

January 19, 2023 at 07:46PM Guidance and Other Information of Special Interest to MCM Stakeholders

Information of particular interest to sponsors/applicants of medical countermeasures to treat, prevent, diagnose, and detect chemical, biological, radiological, and nuclear threats and emerging infectious diseases

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Hd5742P

January 19, 2023 at 05:29PM Adacel

Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/utzipgO

January 19, 2023 at 01:32PM Antimicrobial Resistance Information from FDA

Antimicrobial resistance (AMR)—the ability of a microorganism (bacteria, virus, fungi, parasite) to resist the effects of a drug—is a serious, complex and costly public health problem. Learn what FDA is doing to address AMR.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/4CYpPhI

Wednesday, January 18, 2023

January 18, 2023 at 09:53PM Approved New Drug Applications (NDAs) and Abbreviated New Drug Applications (ANDAs) with Supporting Documents for CBER-Regulated Products

List including applications in alphabetical order by product name for which have approval documents available, and reflects the information as of the approval date.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/WZ2PgIQ

January 18, 2023 at 06:52PM Vaccines, Blood & Biologics

From blood to vaccines, FDA protects and advances the public health by ensuring that biological products are safe, effective, and available to those who need them. Read these Consumer Updates to learn more.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/5nT9yP1

January 18, 2023 at 02:41PM Jobs at the Center for Biologics Evaluation and Research (CBER)

CBER has unique opportunities for individuals with backgrounds in science or administration to fill positions involved in the regulation and research of blood, vaccines and therapeutics.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/kP8QGUA

Tuesday, January 17, 2023

January 17, 2023 at 02:34PM Clinical Investigator Administrative Actions - Disqualification

Information Sheet Guidance for IRBs, Clinical Investigators, and Sponsors: Clinical Investigator Administative Actions - Disqualification

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/5mRWExD

January 17, 2023 at 08:38PM Drugs@FDA Data Files

Drugs@FDA Downloadable Data File in ZIP format, Data Definitions, and Entity Relationship Diagram (ERD)

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/lAmHXiE

January 17, 2023 at 04:39PM Cellular & Gene Therapy Guidances

This page contains a listing of cellular and gene therapy guidances.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/I8xWSBC

Thursday, January 12, 2023

January 12, 2023 at 04:47PM ADSTILADRIN

For the treatment of High-grade, Bacillus Calmette-Guerin (BCG) unresponsive non-muscle invasive bladder cancer.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/VUpyHKd

Wednesday, January 11, 2023

January 11, 2023 at 09:09PM COVID-19 Vaccines

FDA has rigorous scientific and regulatory processes in place to facilitate development and ensure the safety, effectiveness and quality of COVID-19 vaccines.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/No71DnI

January 11, 2023 at 07:39PM Tissue Reference Group

This update includes recommendations for FY 2015 for the Tissue Reference Group.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/ShptK6Q

January 11, 2023 at 05:57PM Labeling and Promotion Guidances

This page lists Labeling and Promotion Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/4XrUO71

January 11, 2023 at 05:21PM Vaccines and Related Biological Products Advisory Committee January 26, 2023 Meeting Announcement - 01/26/2023

This is the main page for the CBER Vaccines and Related Biological Products Advisory Committee (VRBPAC) January 26, 2023 Meeting Announcement and meeting materials.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/HeVTbv2

Tuesday, January 10, 2023

January 10, 2023 at 11:07PM Biologics Electronic Reading Room (eFOI)

The Biologics eFOI Reading Room provides access to documents posted throughout the "Vaccines, Blood & Biologics" and other sections related to the Center for Biologics Evaluation and Research on the FDA.gov Web site.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/1dXiyMK

January 10, 2023 at 09:49PM Regenerative Medicine Advanced Therapy Designation

Eligibility requirements for a regenerative medicine advanced therapy (RMAT) designation. Information on when and where to submit the request is also provided.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/QURLE2W

Monday, January 9, 2023

January 09, 2023 at 10:50PM Fast Track Designation Request Performance

The Food and Drug Administration Modernization Act of 1997 (FDAMA) includes Section 112, "Expediting study and approval of fast track drugs." This section mandates the Agency to facilitate the development and expedite review of drugs and biologics intended to treat serious or life-threatening conditions and that demonstrate the potential to address unmet medical needs. Fast track adds to existing programs, such as accelerated approval, the possibility of a "rolling submission" for a marketing application. An important feature of fast track is that it emphasizes the critical nature of close early communication between the FDA and sponsor to improve the efficiency of product development.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/Fh3XIGz

January 09, 2023 at 08:43PM Roster of the Allergenic Products Advisory Committee

As part of the Food and Drug Administration's (FDA's) ongoing efforts to recruit qualified experts with minimal conflicts of interest who are interested in serving on FDA advisory committees, FDA is requesting nominations for members to serve on its advisory committees.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/tKGwRfi

January 09, 2023 at 04:55PM Patient Engagement Collaborative

The Patient Engagement Collaborative (PEC) is an advancement in the FDA’s efforts to strengthen its relationship with patient communities and is being coordinated by the FDA’s Office of Patient Affairs in the Office of Clinical Policy and Programs (OCPP).

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/qh61P40

Friday, January 6, 2023

January 06, 2023 at 05:26PM Consumer Updates

Science-based health and safety information you can trust.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/mFSk9gI

January 05, 2023 at 08:21PM ROTARIX

Rotarix approval page indicated for the prevention of rotavirus gastroenteritis caused by G1 and non-G1 types (G3, G4, and G9), for use in infants 6 weeks to 24 weeks of age.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/TpabflL

January 05, 2023 at 06:57PM Have You Given Blood Lately?

FDA works to ensure the safety of the more than 14 million units of blood and blood components donated in the U.S. each year. Learn how FDA helps safeguard the blood supply and how you can donate blood.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/CvP7Fx5

January 04, 2023 at 09:53PM Administrative Guidances

This page lists Administrative Guidance documents.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/NSadUow

January 04, 2023 at 08:12PM Roster of the Cellular, Tissue and Gene Therapies Advisory Committee

This is the Roster of the Cellular, Tissue and Gene Therapies Advisory Committee.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/65eZapu

January 04, 2023 at 07:07PM Jobs at the Center for Biologics Evaluation and Research (CBER)

CBER has unique opportunities for individuals with backgrounds in science or administration to fill positions involved in the regulation and research of blood, vaccines and therapeutics.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/NIGEsyB

Tuesday, January 3, 2023

January 03, 2023 at 05:03PM Patient Listening Session Summaries

Patient Listening Session summaries are published after each session to share a high-level summary of the discussion. The Office of Patient Affairs draft summaries for FDA-requested sessions and the patient community requester drafts summaries for Patient-led sessions.

via Whats New Vaccines Blood Biologics RSS Feed https://ift.tt/nkgjfrH